Coronavirus Outbreak: Magicians Stay At Home & Work Remotely By Using Zoom | Behind The Hustle Ep.06
About this video
Guest Bret interviews Daniel Chan, a Silicon Valley magician who has performed over 5,000 shows for major tech companies. The discussion explores Chan’s business model—working up the magic industry hierarchy from library shows to corporate events—and how he’s adapting his act to the COVID-19 era by pivoting to Zoom performances, which presents unique challenges since magic relies on in-person sleight of hand and the audience’s uncertainty.
Key takeaways
- Creative professionals like magicians require the same business acumen as tech entrepreneurs, including pricing strategy, client segmentation, and business model innovation
- Bret notes that magicians face a structural challenge moving to Zoom: the technology introduces uncertainty about manipulation, undermining magic’s core appeal, so Chan has had to simplify his tricks rather than overcomplicate them
- The pandemic creates a meta-challenge for magic as a business—people’s existing anxiety about the unknown makes them less receptive to magic as entertainment celebrating mystery
Episode details: published May 8, 2020 · 880 views · 4:21 long. Summary written by Self Growth Videos from the episode itself. The business ideas, figures and results discussed are the hosts’ and guests’ own claims, shared as brainstorming and entertainment — not verified facts and not investment advice.
← Previous: How We Will Grow Our Podcast With Sam Parr & Shaan Puri Podcasting 101 | My First Million 04-16-2020 · Next: This Profitable Business Model Might Make You A Billionaire | My First Million Podcast →
All My First Million videos · My First Million profile · My First Million (official site)
You Might Also Enjoy

13 Businesses Making +$1,000,000/Year With 0 Employees
Explore →
Every successful startup starts with this one advantage
Explore →
3 businesses we think are about to blow up
Explore →
We tested Instinct, Muse and Grokbot. They’re ridiculous.
Explore →
The $4 billion business behind drug testing
Explore →